Evidence map›Paper›PMID 23847771›Full record

ReviewFrontiers in cellular and infection microbiology2013

Tick vaccines and the control of tick-borne pathogens.

Octavio Merino, Pilar Alberdi, José M Pérez de la Lastra, José de la Fuente

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 112 citations in OpenAlex.

  1. Why are the ticks winning, and what can we do about it?Ticks and tick-borne diseases · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Frontiers in microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Co-Immunization Efficacy of Recombinant Antigens againstPathogens (Basel, Switzerland) · 2023
    Article
  11. Molecular detection and characterization ofFrontiers in veterinary science · 2023
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Repellency and toxicity of a COExperimental & applied acarology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Octavio MerinoSaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM Ciudad Real, Spain.
Pilar Alberdi
José M Pérez de la Lastra
José de la Fuente
Instituto de Investigación en Recursos Cinegéticos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ticks are obligate hematophagous ectoparasites that transmit a wide variety of pathogens to humans and animals. The incidence of tick-borne diseases has increased worldwide in both humans and domestic animals over the past years resulting in greater interest in the study of tick-host-pathogen interactions. Advances in vector and pathogen genomics and proteomics have moved forward our knowledge of the vector-pathogen interactions that take place during the colonization and transmission of arthropod-borne microbes. Tick-borne pathogens adapt from the vector to the mammalian host by differential gene expression thus modulating host processes. In recent years, studies have shown that targeting tick proteins by vaccination can not only reduce tick feeding and reproduction, but also the infection and transmission of pathogens from the tick to the vertebrate host. In this article, we review the tick-protective antigens that have been identified for the formulation of tick vaccines and the effect of these vaccines on the control of tick-borne pathogens.

Indexed as

AnimalsArachnid VectorsEctoparasitic InfestationsHumansTick-Borne DiseasesTicksVaccinesVaccinesticktick-borne pathogenstransmission-blockingvaccinevector

Identifiers

PMID23847771
PMCPMC3705209
OpenAlexW2134946023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.